Synthesis, Antioxidant and Some Enzyme Inhibition Activities of New Sulfonyl Hydrazones and their Molecular Docking Simulations

Aktar B. S. K., Sicak Y., TATAR YILMAZ G., Oruc-Emre E. E.

PHARMACEUTICAL CHEMISTRY JOURNAL, vol.56, no.4, pp.559-569, 2022 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 56 Issue: 4
  • Publication Date: 2022
  • Doi Number: 10.1007/s11094-022-02674-3
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, Chemical Abstracts Core, EMBASE
  • Page Numbers: pp.559-569
  • Keywords: sulfonyl hydrazine, antioxidant, anticholinesterase, tyrosinase, urease, molecular docking, ALZHEIMERS-DISEASE, ACETYLCHOLINESTERASE, CHALCONES, BINDING
  • Karadeniz Technical University Affiliated: Yes


In this work, a series of new sulfonyl hydrazones were synthesized and screened for antioxidant and anticholinesterase, tyrosinase and urease enzyme inhibition activities. In addition, molecular docking study was applied to better understand the inhibitory mechanism at the molecular level. Further, bioavailability of the synthesized compounds is considered in terms of the Lipinski rule and the design of their pharmacokinetic and pharmacodynamic properties is found reliable. In the AChE activity assay results, compound 8 was the most active one, while being less active than galantamine that was used as the standard drug. In the BChE activity testing of sulfonyl hydrazone derivatives (1-8), , compounds 3, 4, 5, 6, 7 and 8 were the most active drugs and showed much better activity than galantamine used as the standard. Compounds 8, 5 and 4 showed the best tyrosinase inhibitory activity with IC50 values of 9.75 +/- 0.23, 13.18 +/- 0.67 and 16.29 +/- 0.73 mM, respectively.